A phase 1 study of savolitinib in recurrent, progressive, or refractory medulloblastoma, high-grade glioma, diffuse intrinsic pontine glioma, and central nervous system (CNS) tumors harboring met aberrations: A Pediatric Brain Tumor Consortium trial Meeting Abstract


Authors: Salloum, R.; Huang, J.; Stewart, C. F.; Fuller, C.; Smolarek, T.; Lenzen, A.; Waanders, A. J.; Baxter, P.; Lindsay, H.; Robison, N.; Pillay-Smiley, N.; Partap, S.; Fangusaro, J.; Onar-Thomas, A.; Fouladi, M.; Dunkel, I. J.
Abstract Title: A phase 1 study of savolitinib in recurrent, progressive, or refractory medulloblastoma, high-grade glioma, diffuse intrinsic pontine glioma, and central nervous system (CNS) tumors harboring met aberrations: A Pediatric Brain Tumor Consortium trial
Meeting Title: Society for Neuro-Oncology’s 7th Biennial Pediatric Neuro-Oncology Research Conference
Journal Title: Neuro-Oncology
Volume: 25
Issue: Suppl. 1
Meeting Dates: 2023 Jun 22-24
Meeting Location: Washington, D.C.
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2023-06-01
Start Page: i81
Language: English
ACCESSION: WOS:001023504300315
DOI: 10.1093/neuonc/noad073.314
PROVIDER: wos
Notes: Meeting Abstract: TRLS-11 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ira J Dunkel
    371 Dunkel